Brind.

Artisan Small Cap Fund highlighted Madrigal Pharmaceuticals stock.

1 report, 1 independent Updated Aug 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Madrigal Pharmaceuticals (United States)fund

How it developed

Newest first. Tap a step to see who reported it.

Jun 8Xavier Madrigal-Sánchez, who operates in the biopharmaceutical sector, was noted for his professional context and the underperformance of the company he is associated with.Sub-event
Aug 25Artisan Small Cap Fund highlighted Madrigal Pharmaceuticals stock.1 source
- Insider Monkey

Keep exploring

The entities involved

Madrigal Pharmaceuticals (United States)
company in West Conshohocken, United States
- Novo Nordisk's Wegovy received FDA approval for treating MASH, posing a competitive challenge to Madrigal Pharmaceuticals' Rezdiffra.Sun 05:16
fund
organization or foundation that holds funds
- A fund was listed on the New York Stock Exchange on September 11, 2026.Mon 15:48
- Prospect Capital Corporation expects to file a report with the Securities and Exchange Commission.Sun 04:13

Coverage

Newest first; wire copies grouped

Aug 25Insider MonkeyDo You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)? Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor lette